BEARZI, ITALO
 Distribuzione geografica
Continente #
NA - Nord America 3.748
EU - Europa 2.080
AS - Asia 479
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 2
Totale 6.317
Nazione #
US - Stati Uniti d'America 3.737
UA - Ucraina 559
SE - Svezia 345
IE - Irlanda 284
DE - Germania 241
TR - Turchia 238
DK - Danimarca 214
IT - Italia 210
FI - Finlandia 122
KR - Corea 112
SG - Singapore 95
GB - Regno Unito 65
CN - Cina 25
BE - Belgio 13
CA - Canada 11
FR - Francia 10
EU - Europa 8
IN - India 7
RU - Federazione Russa 6
GR - Grecia 4
NL - Olanda 3
AU - Australia 2
RS - Serbia 2
CZ - Repubblica Ceca 1
HK - Hong Kong 1
LT - Lituania 1
PK - Pakistan 1
Totale 6.317
Città #
Chandler 589
Jacksonville 564
Fairfield 349
Dublin 282
Wilmington 210
Ashburn 202
Boardman 162
Woodbridge 159
Houston 137
Ann Arbor 129
Cambridge 124
Seattle 122
San Mateo 114
Lawrence 113
Princeton 113
New York 93
Des Moines 73
Centro 50
San Diego 43
Beijing 19
Venice 14
Turin 13
Brussels 11
Izmir 11
Helsinki 10
London 9
Norwalk 9
Auburn Hills 4
Como 4
Kilburn 4
Montréal 4
Ottawa 4
Pune 4
Thessaloníki 4
Mountain View 3
Pesaro 3
Porto 3
Toronto 3
Acton 2
Belgrade 2
Los Angeles 2
Marche 2
Milan 2
Nanjing 2
Prescot 2
Sydney 2
Tappahannock 2
Waanrode 2
Washington 2
Amsterdam 1
Brooklyn 1
Burlington 1
Chengdu 1
Copenhagen 1
Dallas 1
Edinburgh 1
Euless 1
Fiano 1
Hanover 1
Hebei 1
Jablonec nad Nisou 1
Kolkata 1
Limerick 1
Liverpool 1
Morrovalle 1
Napoli 1
New Bedfont 1
Ningbo 1
Ostra 1
Ratoath 1
Redwood City 1
Rome 1
Saint Petersburg 1
Santa Clara 1
Shanghai 1
Simi Valley 1
Southwark 1
Stamford 1
Vallefoglia 1
Vilnius 1
Woodhall Spa 1
Totale 3.818
Nome #
Predictive and prognostic role of E-cadherin protein expression in patients with advanced gastric carcinomas treated with palliative chemotherapy. 101
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab. 98
Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study. 93
The G/A nucleotide change at cDNA position 2494 in the E-cadherin gene (CDH1): analysis in Italian patients. 90
'Secrets and lies'--the difficulties of communicating within families with inherited cancer syndromes. 87
A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-Italy. 85
T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. 84
Localized amyloidosis and gastrointestinal lymphoma: a rare association. 84
Long–term follow-up in early gastric cancer: evaluation of prognostic factors. 81
[Further contribution to the ultrastructure of spleen in Cooley's disease]. 79
Anti-human versus anti-guinea pig tissue transglutaminase antibodies as the first-level serological screening test for coeliac disease in the general population. 79
Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features. 78
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 78
Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression. 77
An intronic mutation in MLH1 associated with familial colon and breast cancer. 77
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 76
Storage cells of spleen and bone marrow in thalassemia: an ultrastructural study. 74
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 73
[Ultrastructural aspects of the PAS-positive histiocytic giant cells of the spleen in Cooley's disease]. 73
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab. 73
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 72
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 72
Significance of diffuse granularity and nodularity of the esophageal mucosa at double-contrast radiography. 71
A "G insertion" at nucleic acids 481 of the H. pylori fldA gene is not associated with gastric MALT lymphoma. 70
[Effects of the conditioning with estradiol on the development of experimental amyloidosis in mice]. 69
A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. 68
Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies. 67
Cutaneous Kikuchi's disease: report of a new case and review of the literature. 66
A clinicopathological study of 152 surgically treated primary gastric lymphomas with survival analysis of 109 high grade tumours. 65
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients. 65
Prognostic role of thymidylate synthase polymorphisms in gastric cancer patients treated with surgery and adjuvant chemotherapy. 64
Adenocarcinoma arising from ileoanal J- Pouch mucosa: An announced event? 64
Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype. 64
Nuclear factor-κB predicts outcome in locally advanced rectal cancer patients receiving neoadjuvant radio-chemotherapy. 64
A flow cytometric study of early gastric cancer. The detection of high proliferative activity adds important information to the prognosis. 64
Screening E-cadherin germline mutations in Italian patients with familial diffuse gastric cancer: an analysis in the District of Urbino, Region Marche, Central Italy. 63
Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy. 63
Hedgehog (Hh) Signaling is a Predictor of Clinical Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC). 63
Peritoneal leiomyosarcoma in a kidney transplant patient: a case report. 63
Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients. 62
Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation 62
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 62
MSH2 splice site mutation and endometrial cancer. 61
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 61
Gastric Dysplasia: A Ten-year Follow-up Study. 60
MR imaging of ulcerative colitis. 59
Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. 59
T-cell prolymphocytic leukaemia: does the expression of CD8+ phenotype justify the identification of a new subtype? Description of two cases and review of the literature. 57
Antiendomysium versus antigliadin antibodies in screening the general population for coeliac disease. 57
Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy. 57
Insulin-like Growth Factor (IGF) 1 and 2 help to predict disease outcome in GIST patients 56
[Bronchiolo-alveolar carcinoma in the lung with scleroderma]. 56
Effectiveness of the CRCAPRO program in identifying patients suspected for HNPCC. 55
[Radiologic aspects of the surface mucosa of the duodenal bulb. Correlation with the endoscopic and histological aspects]. 55
Quantitative study of the precancerous and malignant lesions in colorectal adenomas. 55
Synchronous mucosa-associated lymphoid tissue lymphoma and adenocarcinoma of the stomach. 54
Association of thymidylate synthase polymorphisms with gastric cancer susceptibility. 54
Mucosal colonization of gastric endocrine tumors mimicking mixed neoplasms. 53
Centrocytic-like lymphoma associated with localized amyloidosis of the large intestine. 53
Lipid-rich adenoma of the thyroid. 52
Gangliosides, sialoglycoproteins and glucocerebroside in the spleen and bone marrow of patients with beta-thalassemia major. 52
High frequency of CagA+ Helicobacter pylori infection in high-grade gastric MALT B-cell lymphomas. 52
Bone marrow extracellular large geometric crystals in IgG/lambda MGUS. 52
Adenoma-carcinoma sequence of colorectum. Prevalence of K-ras gene mutation in adenomas with increasing degree of dysplasia and aneuploidy. 51
Ploidy, proliferative activity, p53 and bcl-2 expression in bronchopulmonary carcinoids: relationship with prognosis. 51
Sequence analysis of the hepatitis B virus pre-C region in hepatocellular carcinoma [HCC] and nontumoral liver tissues from HCC patients. 51
Ampullary somatostatinoma. An immunohistochemical and ultrastructural study. 51
Gastric duplication communicating with a pancreatic duct. Report of a case. 51
Pulmonary tumor thrombotic microangiopathy: the challenge of the antemortem diagnosis. 51
Coeliac disease in Libyan children: a screening study based on the rapid determination of anti-transglutaminase antibodies. 51
Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables. 50
Growth-factor independence of a new differentiated hepatitis B virus DNA-negative human hepatoma cell line. 50
Antihuman IgA tissue transglutaminase antibodies as screening test for coeliac disease 50
Association of celiac disease and intestinal lymphomas and other cancers. 50
Gastrointestinal stromal tumor. A study of 158 cases: clinicopathological features and prognostic factors. 49
Gastrointestinal stromal tumors: the histology report. 49
[Keratocysts]. 49
Radiologic diagnosis of early gastric cancer by routine double-contrast examination. 49
[Cytochemical and cytogenetic study of a case of Sézary syndrome developing sarcomatous features (author's transl)]. 48
[Campylobacter pyloridis and gastritis: endoscopic, histological and microbiological correlations]. 48
Pleomorphic adenoma of minor salivary gland. 47
Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size. 47
KIT and PDGFR(alpha) mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study. 46
Multiple gastric carcinoids and pernicious anemia: report of a case. 45
Basaloid carcinoma of the sigmoid colon: report of a case. 45
Ultrastructural findings in the jejunal mucosa of children with IgA deficiency. 44
Why is coeliac disease endemic in the people of the Sahara? 44
null 44
Locally advanced rectal cancer patients receiving radio-chemotherapy: a novel clinical-pathologic score correlates with global outcome. 43
Clonal analysis by chromosome 11 microsatellite-PCR of microdissected parathyroid tumors from MEN 1 patients. 43
[Solid pseudopapillary tumor of the pancreas. A report of 3 cases and a review of the literature]. 42
Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer. 41
[Immunoblastic macroglobulinemic reticulosis: morphological cytochemical and immunological study]. 41
Small benign tumors of the esophagus: radiological diagnosis with double-contrast examination. 40
Early gastric cancer: a morphologic study of 41 cases. 40
Traumatic rupture of nodular focal fatty infiltration of the liver: case report. 40
Intravascular bronchioloalveolar tumour. 40
Small bowel adenocarcinoma and Crohn's disease: report of a case with differing histogenetic patterns. 40
Maspin expression is a favorable prognostic factor in non-small cell lung cancer. 40
Celiac disease: A comprehensive current review 40
Totale 5.954
Categoria #
all - tutte 28.982
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.982


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201919 0 0 0 0 0 0 0 0 0 0 4 15
2019/2020662 6 3 115 10 116 4 114 4 119 8 13 150
2020/20211.596 74 184 229 20 174 152 169 82 161 115 166 70
2021/2022813 44 226 8 54 5 51 32 45 46 88 39 175
2022/20231.540 131 145 106 153 161 199 4 104 382 10 119 26
2023/2024650 163 15 40 136 134 118 20 16 0 8 0 0
Totale 6.434